Logo image of FORA

FORIAN INC (FORA) Stock Fundamental Analysis

NASDAQ:FORA - Nasdaq - US34630N1063 - Common Stock - Currency: USD

2.11  +0.02 (+0.96%)

Fundamental Rating

2

FORA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 37 industry peers in the Health Care Technology industry. While FORA seems to be doing ok healthwise, there are quite some concerns on its profitability. FORA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year FORA has reported negative net income.
FORA had a negative operating cash flow in the past year.
In the past 5 years FORA reported 4 times negative net income.
In the past 5 years FORA reported 4 times negative operating cash flow.
FORA Yearly Net Income VS EBIT VS OCF VS FCFFORA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M -20M -30M

1.2 Ratios

FORA has a better Return On Assets (-4.49%) than 75.68% of its industry peers.
FORA has a Return On Equity of -9.60%. This is in the better half of the industry: FORA outperforms 72.97% of its industry peers.
Industry RankSector Rank
ROA -4.49%
ROE -9.6%
ROIC N/A
ROA(3y)-28%
ROA(5y)-27.33%
ROE(3y)-90.72%
ROE(5y)-66.21%
ROIC(3y)N/A
ROIC(5y)N/A
FORA Yearly ROA, ROE, ROICFORA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K

1.3 Margins

FORA has a better Gross Margin (67.03%) than 70.27% of its industry peers.
In the last couple of years the Gross Margin of FORA has grown nicely.
The Profit Margin and Operating Margin are not available for FORA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 67.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.12%
GM growth 5Y14.3%
FORA Yearly Profit, Operating, Gross MarginsFORA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600 -800

More info and screens

4

2. Health

2.1 Basic Checks

FORA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for FORA has been reduced compared to 1 year ago.
FORA has less shares outstanding than it did 5 years ago.
The debt/assets ratio for FORA has been reduced compared to a year ago.
FORA Yearly Shares OutstandingFORA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
FORA Yearly Total Debt VS Total AssetsFORA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

FORA has an Altman-Z score of 0.59. This is a bad value and indicates that FORA is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of FORA (0.59) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.91 indicates that FORA is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.91, FORA is doing worse than 78.38% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Altman-Z 0.59
ROIC/WACCN/A
WACC10.2%
FORA Yearly LT Debt VS Equity VS FCFFORA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 1.85 indicates that FORA should not have too much problems paying its short term obligations.
The Current ratio of FORA (1.85) is better than 62.16% of its industry peers.
FORA has a Quick Ratio of 1.85. This is a normal value and indicates that FORA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.85, FORA is in the better half of the industry, outperforming 62.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.85
FORA Yearly Current Assets VS Current LiabilitesFORA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

2

3. Growth

3.1 Past

FORA shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
The Revenue for FORA has decreased by -14.34% in the past year. This is quite bad
FORA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.46% yearly.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-107.69%
Revenue 1Y (TTM)-14.34%
Revenue growth 3Y235.99%
Revenue growth 5Y16.46%
Sales Q2Q%-12.39%

3.2 Future

The Earnings Per Share is expected to decrease by -101.00% on average over the next years. This is quite bad
Based on estimates for the next years, FORA will show a small growth in Revenue. The Revenue will grow by 4.07% on average per year.
EPS Next Y-372%
EPS Next 2Y-101%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-4.64%
Revenue Next 2Y4.07%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
FORA Yearly Revenue VS EstimatesFORA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
FORA Yearly EPS VS EstimatesFORA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -0.2 -0.4 -0.6 -0.8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

FORA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year FORA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FORA Price Earnings VS Forward Price EarningsFORA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FORA Per share dataFORA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

FORA's earnings are expected to decrease with -101.00% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-101%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

FORA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FORIAN INC

NASDAQ:FORA (3/7/2025, 8:27:39 PM)

2.11

+0.02 (+0.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)03-26 2025-03-26/amc
Inst Owners15.26%
Inst Owner Change13.64%
Ins Owners48.99%
Ins Owner Change5.33%
Market Cap65.45M
Analysts82.86
Price Target5.1 (141.71%)
Short Float %0.79%
Short Ratio2.74
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-112.42%
Min EPS beat(2)-292.16%
Max EPS beat(2)67.32%
EPS beat(4)2
Avg EPS beat(4)-22.55%
Min EPS beat(4)-292.16%
Max EPS beat(4)230.72%
EPS beat(8)6
Avg EPS beat(8)66.58%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.77%
Min Revenue beat(2)-10.98%
Max Revenue beat(2)-4.56%
Revenue beat(4)0
Avg Revenue beat(4)-6.83%
Min Revenue beat(4)-10.98%
Max Revenue beat(4)-4.56%
Revenue beat(8)2
Avg Revenue beat(8)-4.99%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.32
P/FCF N/A
P/OCF N/A
P/B 2.43
P/tB 2.43
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.64
BVpS0.87
TBVpS0.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.49%
ROE -9.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 67.03%
FCFM N/A
ROA(3y)-28%
ROA(5y)-27.33%
ROE(3y)-90.72%
ROE(5y)-66.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.12%
GM growth 5Y14.3%
F-Score2
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 11.9%
Cap/Sales 0.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 1.85
Altman-Z 0.59
F-Score2
WACC10.2%
ROIC/WACCN/A
Cap/Depr(3y)77.67%
Cap/Depr(5y)151.08%
Cap/Sales(3y)5%
Cap/Sales(5y)6.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-107.69%
EPS Next Y-372%
EPS Next 2Y-101%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.34%
Revenue growth 3Y235.99%
Revenue growth 5Y16.46%
Sales Q2Q%-12.39%
Revenue Next Year-4.64%
Revenue Next 2Y4.07%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y30.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year109.79%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y85.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y84.34%
OCF growth 3YN/A
OCF growth 5YN/A